Hot Topics

Crystallization Process Development of Serabelisib (TAK117)

Bulk powder properties (BPPs) of small molecule pharmaceuticals are intricately regulated in the latter stages of API process development. These properties include critical factors such as solubility, density, flowability, and hygroscopicity, each influenced by a combination of particle characteristics, including particle size distribution (PSD), particle shape, moisture content, and chemical composition. The pursuit of optimal […]

Crystallization Process Development of Serabelisib (TAK117) Read More »